Ann: Appendix 4C - quarterly, page-139

Interesting read tiger, seven investors putting up 10 mill, in a private company, impressive, (Side note; be interesting to know HOW many sophisticated investors/ funds there actually was at last CR)

Following observation, pie in the sky, one;

Wonder if Admedus has ever put the ruler over a acquisition that could have complemented its existing IP and bring about successful commercialisation of its IP in a timely manner.

CR for a acquisition would be far more palatable than one to continue operating from month to month.

In regards to the continual negotiating (?) by Admedus with third party/s, will certainly be a tough gig, ‘hat in hand’ and like Oliver, in the novel, ‘can I have more’ not exactly the strongest position to be in.

Does Admedus/WP have the experience to bring about the best possible outcome, think at this point, imo, it may be close to some third party/s getting a stake in this company for ‘seemingly’ peanuts’, IF all Admedus IP is what it should be.

Come Monday (?), resume of trading will be a definite ‘win’, sp holding above 10 cents a definite ‘win’, the question will be at what cost, WILL there be any worth while developments, from this CR, that will change sentiment for this stock.